GlaxoSmithKline Chairman Sir Philip Hampton will step down from his role ahead of the company’s plan to split into two separate business units.

Pfizer, which was considering a split into two companies for more than two years, said it would not do so because the move would not create any shareholder value.

Medivir AB announced that it plans to split up into two independent companies.